咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >A multicenter,*** survey of th... 收藏

A multicenter,*** survey of the clinical features and management of bone metastatic disease in China

A multicenter,*** survey of the clinical features and management of bone metastatic disease in China

作     者:Yunpeng Yang Yuxiang Ma Jin Sheng Yan Huang Yuanyuan Zhao Wenfeng Fang Shaodong Hong Ying Tian Cong Xue Li Zhang 

作者机构:Department of Medical OncologySun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South ChinaCollaborative Innovation Center for Cancer Medicine 

出 版 物:《Chinese Journal of Cancer》 (Chinese Journal of Cancer)

年 卷 期:2016年第35卷第5期

页      面:223-228页

核心收录:

学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

基  金:Novartis 

主  题:Bisphosphonates, Bone metastases, Skeleton-related events, Chinese cancer patients 

摘      要:Background:Bone metastases are common in patients with advanced ***(BPs) could prevent or delay the development of skeleton-related events(SREs).The present study aimed to identify the clinical features of and treatment strategies for Chinese patients with bone ***:Consecutive cancer patients who had bone metastases and received BP treatment were enrolled.A questionnaire was developed to collect the patients clinical data,as well as information on the diagnosis and management of bone *** awareness of the guidelines and knowledge of the application of BP were also ***:A total of 3223 patients with lung cancer(36.5%),breast cancer(30.9%),prostate cancer(8.5%),and gastrointestinal cancer(5.7%) were included in this *** sites of bone metastases were the thoracic spine(56.0%),lumbar spine(47.1%),ribs(32.6%),and pelvis(23.2%).The SRE frequency was the highest in patients with multiple myeloma(36.6%),followed by those with lung cancer(25.9%),breast cancer(20.2%),prostate cancer(18.2%),and gastrointestinal cancer(17.3%).Irradiation to the bone was the most frequent SRE(58%in lung cancer patients,45%in breast cancer patients,and 48%in prostate cancer patients).Our survey also showed that 45.5%of patients received BP within 3 months after their diagnosis of bone metastases,whereas the remaining 54.5%of patients did not receive BP treatment until at least 3 months after their diagnosis of bone *** SRE frequency in the former group was significantly lower than that in the latter group(4.0%vs.42.3%,P 0.05).In patients with more than 6 months of continuous BP treatment,the mean time to the first SRE was significantly longer than that in patients with less than 6 months of continuous BP treatment(7.2 vs.3.4 months,P 0.05).In addition,12.2%of the physicians were not aware of the efficacy of BP in preventing and delaying *** half(52.3%) of the physicians agreed that the BP treatment should p

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分